Chief Medical Officer Lance Baldo resigns effective March 25, 2022

Adaptive Biotechnologies Corp

Lance Baldo resigned as Chief Medical Officer to pursue a new opportunity.
Resignation effective March 25, 2022; no replacement named yet.
Baldo stated no disagreement with the company, management, or board.
Event reported under Item 8.01 as an other-event disclosure.

item 8.01

Adaptive Biotechnologies Corp filing history →

Source: SEC EDGAR

accession 0001564590-22-011827

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.